Cobalt (II) Chloride in Enhancing Hypoxia Inducible Factor-1α Expression of Gingival Derived Mesenchymal Stem Cells in Vitro

 

Alexander P. Nugraha1, Igo S. Ihsan2, Aristika Dinaryanti2, Eryk Hendrianto2, Helen Susilowati3, Eric P. Prasetyo4,

Ida B. Narmada1, Diah S. Ernawati5*, Andreas P. Nugraha6, Viol Dhea Kharisma7, Wibi Riawan8, Fedik A. Rantam3,9

1Department of Orthodontics, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia.

2Stem Cell Research and Development Center, Universitas Airlangga, Surabaya, Indonesia.

3Research Center of Vaccine Technology and Development, Universitas Airlangga, Surabaya, Indonesia.

4Department of Conservative Dentistry, Faculty of Dental Medicine,

Universitas Airlangga, Surabaya, Indonesia.

5Department of Oral Medicine, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia.

6Oral and Maxillofacial Surgery Resident, Faculty of Dental Medicine,

Universitas Airlangga, Surabaya, Indonesia.

7Department of Biology, Faculty of Mathematics and Natural Science,

Brawijaya University, Malang, Indonesia.

8Department of Biomolecular Biochemistry, Faculty of Medicine, Brawijaya University, Malang, Indonesia

9Laboratory of Virology and Immunology, Department of Microbiology, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia.

*Corresponding Author E-mail: diah-s-e@fkg.unair.ac.id

 

ABSTRACT:

Despite gingival derived mesenchymal stem cells (GDMSCs) are unique and have numerous advantages for regenerative dentistry, the hypoxia preconditioning of GDMSCs may be essential prior to the transplantation. The aim of this study is to examine whether CoCl2 can enhance HIF-1α in GDMSCs in vitro. GDMSCs of Rabbit (Oryctolagus cuniculus) were obtained from laboratory stock. The sample for this study was randomly selected and divided into 4 groups; GDMSC normoxia (24 hours and 48 hours) groups and GDMSC hypoxia (24 hours and 48 hours) groups respectively (N=20/n=5). To stimulate the hypoxia condition, the final concentration of 100μM Cobalt (II) Chloride (CoCl2) was used in this study. The examination of Hypoxia Inducible Factor-1α (HIF-1α) stimulated with CoCl2 in the GDMSCs utilized immunocytochemistry methods with Fluorescein isothiocyanate antibody labelling. The Tukey Honest Significant Different (HSD) test was conducted to compare the significant difference in HIF-1α expression between groups (p<0.01). The greatest expression of HIF-1α is found in GDMSCs treated with CoCl2 for 24 hours. There was significant difference in HIF-1α expression between GMSCs normoxia (24 hours and 48 hours) and GMSCs hypoxia of 24 hours groups but not 48 hours group (p<0.01). CoCl2 can enhance significantly HIF-1α expression of GDMSCs for 24 hours in vitro.

 

KEYWORDS: Cobalt (II) Chloride, Gingival Derived Mesenchymal Stem Cells, Hypoxia Inducible Factor -1α, Hypoxia preconditioning, Medicine.

 

 


 

INTRODUCTION:

Currently, a study regarding stem cells’ potential ability for treating diseases gains so much attention.1 Stem cells may replace, restore or regenerate the damaged cell, tissue, organ into its normal functions.2 Stem cells own a good potential proliferation rate, self-renewal, differentiation into mesenchymal lineage which are suitable for the regenerative dentistry approach.3 In dentistry field, periodontitis, salivary gland defect, alveolar bone defect, and post orthodontics treatment relapse are problems which may be resolved through a regenerative dentistry approach.4,5,6

 

Mesenchymal Stem Cells (MSCs) are one type of stem cells that can be isolated from various sources such as umbilical cords7, adipose tissue8, hair follicle9 and orofacial region. Nowadays, orofacial derived MSCs studies are emerging and promising. MSCs are usually from orofacial region, such as gingival derived mesenchymal stem cells (GDMSCs)10, dental pulp stem cell from permanent or deciduous tooth.11-13 MSCs may secrete various growth factors that help the wound healing process.14

 

GDMSCs are unique and suitable for tissue engineering.15 GDMSCs can be easily isolated with minimally invasive procedure. GDMSCs express the MSCs surface marker such as CD73, CD90, CD105 and lack of CD45 expression.10 GDMSCs also differentiate into mesenchymal lineage like osteogenic differentiation confirmed by the expressions of alkaline phosphatase, osteocalcin, osteopontin, osteonectin, Runt-related transcription factor 2 as bone marker.16-20

 

The isolated MSCs exhibit the decreased proliferation, differentiation, and survival. In addition, the strategy to improve their ability are needed.21 The preconditioning of MSCs during culture maybe affect their stemness. Hypoxia preconditioning induces the adaptive state and maintain the stemness of MSCs.22 The MSCs culture in vitro niche do not refer to its normal niche of MSCs which is hypoxia in some tissue (4-7% of oxygen).23 For that reason, before any clinical application, the MSCs characteristic should be maintained through preconditioning the culture in vitro.22 The Cobalt Chloride (CoCl2) can be used as hypoxia mimicking agent (HMA) that induces the hypoxia inducible factor-1α (HIF-1α) expression in the cell culture.24 Therefore, the aim of this study is to confirm that CoCl2 can stimulate HIF-1α expression in GDMSCs in vitro.

 

MATERIAL AND METHODS:

Study Design and Ethical Clearance Approval:

GDMSCs from rabbit (Oryctolagus cuniculus) were obtained from laboratory stock of Stem Cell Research and Development Center, Universitas Airlangga. GDMSCs were the sample for this study, randomly selected and divided into 4 groups GDMSC normoxia (24 hours and 48 hours) groups and GDMSC hypoxia (24 hours and 48 hours) groups respectively (N=20/n=5). In addition, this is a true experimental laboratory post-test only control group study design and ethically approved by the ethical Clearance Committee of Health Research from the Faculty of Veterinary, Universitas Airlangga, Surabaya, Indonesia with reference number of 2.KE.017.02.2020.

 

The Preparation of GDMSCs Treated with CoCl2 :

At fourth passage of GDMSCs cultured in M24 culture well was used in this study. To stimulate the hypoxia condition, CoCl2 (Sigma Aldrich, US) was prepared immediately prior to the administration in a 25mM stock solution in sterile DD water. The final concentration of 100μM CoCl2 was utilized in this study then added to the culture media of GDMSCs and incubated for 24 hours and 48 hours in the incubator (Esco Micro Pte. Ltd, Changi, Singapore) (37°C; 5% C02). Meanwhile, for the normoxia groups, GDMSCs was incubated in the incubator for 24 hours and 48 hours without treated with CoCl2.24

 

The Examination of Hypoxia Inducible Factor-1α Expression in the GDMSCs:

The post incubation lasted for 24 hours or 48 hours. Each group of GDMSCs in each well (n=5) was washed by using PBS and fixed with 4% paraformaldehyde. The examination of HIF-1α stimulated by CoCl2 in the GDMSCs was using immunocytochemistry methods with Fluorescein isothiocyanate antibody labelling (Cat no. ab6717, Abcam, MA, USA). The observation of HIF-1α positive expression (green color) of GDMSCs used the inverted microscope equipped with fluorescence filter (Olympus, Tokyo, Japan) in 100x magnification.9

 

Statistical Analysis :

The Tukey Honest Significant Different (HSD) test from Statistical Package for Social Science (SPSS) 20.0 version (Chicago, Illinois, USA) was performed to compare the significant difference in HIF-1α expression between groups (p<0.01).

 

Fig 1. The HIF-1α expression in GDMSCs (green color) was successfully stimulated by 100mM CoCl2 for 24 hours incubation (hypoxia) and the control (normoxia) observed by using fluorescence inverted microscope (Olympus, Tokyo, Japan) with 100x magnification.

 

The HIF-1α expression in GDMSCs was successfully stimulated by 100mM CoCl2 (see Figure 1). The greatest expression of HIF-1α was found in GDMSCs treated with CoCl2 for 24 hours. The lowest expression of HIF-1α was found in GDMSCs normoxia condition in 24 hours. There was significant difference in HIF-1α expression between GMSCs normoxia (24 hours and 48 hours) and GMSCs hypoxia of 24 hours groups but not 48 hours group (p<0.01) as shown in Figure 2.

 

 

Fig 2. The assessment of HIF-1α expression of GDMSCs with CoCl2 (hypoxia) or without CoCl2 (normoxia) for 24 hours and 48 hours of incubation described as average and standard deviation. Information: *significant different at p<0.01.

 

This study finds that CoCl2 can stimulated the HIF-1α expression of GDMCs. The greatest expression of HIF-1α is found in GDMSCs treated with CoCl2 (hypoxia condition) for 24 hours. In comparison, the lowest HIF-1α expression is detected in GDMSCs normoxia condition in 24 hours. There was significant different in HIF-1α expression between GMSCs normoxia condition (24 hours and 48 hours) and GMSCs hypoxia condition of 24 hours groups but not with 48 hours group. Our study result is in line with Lambertini et al. and Wu’s studies that mentioned the HIF-1α expression is significantly increased in the MSCs post administration of CoCl2 as HMA.24,25 Teti et al study also supported this study result which showed that the hypoxic condition is successfully induced in dental pulp MSCs and umbilical Cord MSCs by utilizing CoCl2.26 Additionally, CoCl2 did not affect the cell viability percentage but successfully induce hypoxic preconditioning in Human Adipose Derived Mesenchymal Stem Cells.27 Hypoxia preconditioning is the characteristic of MSCs endogenous niche. Hypoxia preconditioning of MSCs is able to delay the cell aging, prolongs the cellular life span and survival, and also maintains the stemness of MSCs related genes.22,28,29

 

The MSCs transplantation in the targeted tissue is an essential step of MSCs regenerative treatment. The hypoxia preconditioning of MSCs can improve the skeletal regeneration through the enhancement of neovascularization compared to MSCs in normoxic condition.30 MSCs secrete the homing factors which play important role for movement/migration towards the targeted tissue that is stimulated with hypoxic conditions.31

 

Beside the enhancement of others molecular markers, HIF-1α is the most important cellular regulator in the hypoxia condition. HIF-1α can enhance the genes that involve in the metabolism of glucose, iron transport, neovascularization, and erythropoiesis.32 The ability of CoCl2 as a hypoxia mimicking agent through the inhibition of FIH and HIF-P4Hs causes the occupation of Fe2+ binding site and the blockade of HIF-1α degradation.33

 

Despite GDMSCs are unique and have numerous advantages for regenerative dentistry, the hypoxia preconditioning of GDMSCs may be necessary before the transplantation. In addition, the successfulness of GDMSCs transplantation for MSCs-based regenerative approach depends on the maintenance and the stabilization of the physiological oxygen condition in MSCs.34 Based on the result above, we can conclude that CoCl2 can enhance significantly HIF-1α expression of GDMSCs for 24 hours in vitro. Further studies are still needed to examine the mechanism CoCl2 on HIF-1α expression in others MSCs.

 

ACKNOWLEDGEMENT:

This study was supported by research grant of Penelitian Dasar Unggulan Perguruan Tinggi (PDUPT)  number:306/UN3.15/PT/2021  from Ministry of Research, Technology and Higher Education, Republic of Indonesia. The authors thank the Stem Cell Development and Center, Publication and Research Center, Faculty of Dental Medicine, Universitas Airlangga for supporting our study.

 

CONFLICT OF INTEREST:

The authors declare no conflict of interest.

 

REFERENCES:

1.      Tiwari RK, Sharma V, Pandey R, Shukla RS. Stem Cells: Basics and its Prospective uses in Medical field. Research J. Pharm. and Tech 2018; 11(4): 1530-1534.

2.      Nugraha AP, Rezkita F, Puspitaningrum MS, Luthfimaidah MS, Narmada IB, Prahasanti C, Ernawati DS, Rantam FA. Gingival Mesenchymal Stem Cells and Chitosan Scaffold to Accelerate Alveolar Bone Remodelling in Periodontitis: A Narrative Review. Research J. Pharm. and Tech 2020; 13(5): 2502-2506.

3.      Azeem S, Raj S, Kajal K, Thiagarajan P. Umbilical Cord Stem Cells: A Review. Research J. Pharm. and Tech 2018; 11(6): 2709-2714.

4.      Narmada IB, Laksono V, Nugraha AP, Ernawati DS, Winias S, Prahasanti C, Dinaryanti A, Susilowati H, Hendrianto E, Ihsan IS, Rantam FA. Regeneration of Salivary Gland Defects of Diabetic Wistar Rats Post Human Dental Pulp Stem Cells Intraglandular Transplantation on Acinar Cell Vacuolization and Interleukin-10 Serum Level. Pesquisa Brasileira em Odontopediatria e Clínica Integrada 2019; 19(e5002): 1-10.

5.      Rezkita F, Wibawa KGP, Nugraha AP. Curcumin loaded Chitosan Nanoparticle for Accelerating the Post Extraction Wound Healing in Diabetes Mellitus Patient: A Review. Research J. Pharm. and Tech. 13(2): February 2020.1039

6.      Nugraha AP, Rezkita F, Putra KG, Narmada IB, Ernawati DS, Rantam FA. Triad Tissue Engineering: Gingival Mesenchymal Stem Cells, Platelet Rich Fibrin and Hydroxyapatite Scaffold to ameliorate Relapse Post Orthodontic Treatment. Biochem. Cell. Arch. 2019; 19(2): 3689-3693.

7.      Prasetyo EP, Widjiastuti I, Cahyani F, Kuntjoro M, Hendrijantini N, Hariyani N, et al. Cytotoxicity of calcium hydroxide on human umbilical cord mesenchymal stem cells. Pesqui Bras Odontopediatria Clín Integr. 2020; 20:e0044.

8.      Sari DS, Maduratna E, Ferdiansyah, Latief FDE; Satuman, Nugraha AP, Sudiana K, Rantam FA. Osteogenic Differentiation and Biocompatibility of Bovine Teeth Scaffold with Rat Adipose-derived Mesenchymal Stem Cells. Eur J Dent. 2019; 13(2): 206-212.

9.      Rantam FA, Nugraha AP, Ferdiansyah F, Purwati P, Bumi C, Susilowati H, Hendrianto E, Utomo DN, Suroto H, Sumartono C, Setiawati R, Prakoeswa CR, Indramaya DM. A Potential Differentiation of Adipose and Hair Follicle-derived Mesenchymal Stem Cells to Generate Neurons Induced with EGF, FGF, PDGF and Forskolin. Research J. Pharm. and Tech. 2020; 13(1): 275-281.

10.   Nugraha AP, Narmada IB, Ernawati DS, Widodo DWW, Lestari P, Dinaryanti A, Hendrianto E, Ihsan IS, Susilowati H. Gingival Mesenchymal Stem Cells from Wistar Rat’s Gingiva (Rattus Novergicus) – Isolation and Characterization (In Vitro Study). J Int Dent Med Res 2018; 11(2): 694-699

11.   Suciadi SP, Nugraha AP, Ernawati DS, Ayuningtyas NF, Narmada IB, Prahasanti C, Dinaryanti A, Ihsan IS, Hendrianto E, Susilowati H, Rantam FA. The Efficacy of Human Dental Pulp Stem Cells in regenerating Submandibular Gland Defects in Diabetic Wistar Rats (Rattus novergicus). Research J. Pharm. and Tech. 2019; 12(4): 1573-1579.

12.   Prahasanti C, Nugraha Ap, Saskianti T, Suardita K, Riawan W, Ernawati DS. Exfoliated Human Deciduous Tooth Stem Cells Incorporating Carbonate Apatite Scaffold Enhance BMP-2, BMP-7 and Attenuate MMP-8 Expression During Initial Alveolar Bone Remodeling in Wistar Rats (Rattus norvegicus). Clinical, Cosmetic and Investigational Dentistry 2020: 12 79–85

13.   Timothy CN, Samyuktha PS, Brundha MP. Dental pulp Stem Cells in Regenerative Medicine – A Literature Review. Research J. Pharm. and Tech 2019; 12(8): 4052-4056.

14.   Nugraha AP, Purwati, Susilowati H, Hendrianto E, Karsari D, Ertanti N, Dinaryanti A, Ihsan IS, Narmada IB, Ernawati DS, Rantam FA. Medicinal Signaling Cells Metabolite Oral Based as a Potential Biocompatible Biomaterial Accelerating Oral Ulcer Healing (In Vitro Study). Eur Dent J 2019; 13(3): 432–436.

15.   El-Sayed KMF, Dörfer CE. Gingival Mesenchymal Stem/Progenitor Cells: A Unique Tissue Engineering Gem. Stem Cells International. 2016; 7154327: 1-16.

16.   Nugraha AP, Narmada IB, Ernawati DS, Dinaryanti A, Hendrianto E, Ihsan IS, Riawan W, Rantam FA. Osteogenic potential of gingival stromal progenitor cells cultured in platelet rich fibrin is predicted by core-binding factor subunit-α1/Sox9 expression ratio (in vitro). F1000Research 2018, 7:1134.

17.   Nugraha AP, Narmada IB, Ernawati DS, Dinaryanti A, Hendrianto E, Ihsan IS, Riawan W, Rantam FA. In vitro bone sialoprotein-I expression in combined gingival stromal progenitor cells and platelet rich fibrin during osteogenic differentiation. Tropical Journal of Pharmaceutical Research December 2018;17(12): 2341-2345.

18.   Nugraha AP, Narmada IB, Ernawati DS, Dinaryanti A, Hendrianto E, Riawan W, Rantam FA. Bone alkaline phosphatase and osteocalcin expression of rat’s Gingival mesenchymal stem cells cultured in platelet-rich fibrin for bone remodeling (in vitro study). Eur J Dent 2018; 12: 566-7

19.   Nugraha AP, Narmada IB, Ernawatı DS, Dınaryantı A, Hendrıanto E, Ihsan IS, Riawan W, Rantam FA. The aggrecan expression post platelet rich fibrin administration in gingival medicinal signaling cells in Wistar rats (Rattus novergicus) during the early osteogenic differentiation (in vitro). Kafkas Univ Vet Fak Derg, 25 (3): 421-425, 2019.

20.   Nugraha AP, Narmada IB, Ernawati DS, Dinaryanti A, Susilowati H, Hendrianto E, Ihsan IS, Riawan W, Rantam FA. Somatic Cells Acceleration by Platelet Rich Fibrin. Indian Vet J 2019; 96(04): 30-34.

21.   Kwon SY, Chun SY, Ha YS, et al. Hypoxia Enhances Cell Properties of Human Mesenchymal Stem Cells. Tissue Eng Regen Med. 2017; 14(5): 595604.

22.   Fotia C, Massa A, Boriani F, Baldini N, Granchi D. Hypoxia enhances proliferation and stemness of human adipose-derived mesenchymal stem cells. Cytotechnology. 2015; 67: 1073-1084.

23.   D’Ippolito G, Diabira S, Howard GA, Roos BA, Schiller PC. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone. 2006; 39: 513–522.

24.   Wu D, Yotnda P. Induction and testing of hypoxia in cell culture. J Vis Exp. 2011; 54:2899.

25.   Lambertini E, Penolazzi L, Angelozzi M, et al. Hypoxia Preconditioning of Human MSCs: a Direct Evidence of HIF-1α and Collagen Type XV Correlation. Cell Physiol Biochem. 2018; 51(5): 22372249.

26.   Teti G, Focaroli S, Salvatore V, Mazzotti E, Ingra L, Mazzotti A, Falconi M. The Hypoxia-Mimetic Agent Cobalt Chloride Differently Affects Human Mesenchymal Stem Cells in Their Chondrogenic Potential. Stem Cells in Cartilage Diseases and Repair. 2018; 3237253: 1-9.

27.   Nugraha AP, Prasetyo EP, Kuntjoro M, Ihsan IS, Dinaryanti A, Susilowati H, Hendrianto E, Narmada IB, Ernawati DS, Nugraha AP, Rantam FA. The Effect of Cobalt (II) Chloride in the Viability Percentage and the Induced Hypoxia Inducible Factor -1α of Human Adipose Mesenchymal Stem Cells (HAMSCs): An In Vitro Study. Sys Rev Pharm 2020; 11(6): 308-314.

28.   Hu X, Wu R, Shehadeh LA, Zhou Q, Jiang C, et al. Severe hypoxia exerts parallel and cell-specific regulation of gene expression and alternative splicing in human mesenchymal stem cells. BMC Genomics. 2014; 15: 303.

29.   Drela K, Sarnowska A, Siedlecka P, Szablowska-Gadomska I, Wielgos M, et al. Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner. Cytotherapy. 2014; 16: 881-892.

30.   Leroux L, Descamps B, Tojais NF et al. Hypoxia preconditioned mesenchymal stem cells improve vascular and skeletal muscle fiber regeneration after ischemia through a wnt4-dependent pathway. Molecular Therapy; 2010; 18(8): 1545–1552.

31.   Saller MM, Prall WC, Docheva D et al. Increased stemness and migration of human mesenchymal stem cells in hypoxia is associated with altered integrin expression. Biochemical and Biophysical Research Communications. 2012; 423(2): 379–385.

32.   Pei M. Environmental preconditioning rejuvenates adult stem cells’ proliferation and chondrogenic potential. Biomaterials 2017; 117: 10–23.

33.   Hirsilä M, Koivunen P, Xu L, Seeley T, Kivirikko KI, Myllyharju J. Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. The FASEB 2005; 19(10): 1308–1310.

34.   Haque N, Rahman MT, Kasim NHA Alabsi AM. Hypoxic Culture Conditions as a Solution for Mesenchymal Stem Cell Based Regenerative Therapy. 2013; 632972: 1-12.

 

 

 

 

Received on 26.05.2020           Modified on 28.06.2020

Accepted on 27.07.2020         © RJPT All right reserved

Research J. Pharm. and Tech. 2021; 14(5):2639-2642.

DOI: 10.52711/0974-360X.2021.00465